Cinctive Capital Management LP Vertex Pharmaceuticals Inc Transaction History

Cinctive Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $2.67 Million - $3.33 Million	11,375 New	11,375 $3.21 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $1.14 Million - $1.35 Million	-5,155 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $912,486 - $1.15 Million	5,155 New	5,155 $1.13 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $2.58 Million - $3.44 Million	-12,467 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $2.71 Million - $3.22 Million	-10,613 Reduced 45.98%	12,467 $3.39 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $3.31 Million - $4.35 Million	14,699 Added 175.38%	23,080 $6.7 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $3.74 Million - $4.64 Million	-18,719 Reduced 69.07%	8,381 $1.99 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $4.52 Million - $6.07 Million	27,100 New	27,100 $5.93 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.